2021
DOI: 10.1016/j.semcancer.2019.10.007
|View full text |Cite
|
Sign up to set email alerts
|

Repurposing antipsychotics of the diphenylbutylpiperidine class for cancer therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
37
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
3
1

Relationship

1
7

Authors

Journals

citations
Cited by 61 publications
(41 citation statements)
references
References 64 publications
1
37
0
Order By: Relevance
“…Some compounds investigated in this study, including the antipsychotics diphenylbutylpiperidines fluspirilene, penfluridol, and pimozide and antidepressants such as fluoxetine have been previously reported as autophagy inducers in neurons and in different cancer cell types such as BC and GB by affecting a variety of targets (31,(71)(72)(73). Our study shows that the cytotoxic activity of most of these compounds is essentially based on their common cationic amphiphilic properties and their capacity to perturb acidic intracellular compartments.…”
Section: Discussionmentioning
confidence: 74%
See 1 more Smart Citation
“…Some compounds investigated in this study, including the antipsychotics diphenylbutylpiperidines fluspirilene, penfluridol, and pimozide and antidepressants such as fluoxetine have been previously reported as autophagy inducers in neurons and in different cancer cell types such as BC and GB by affecting a variety of targets (31,(71)(72)(73). Our study shows that the cytotoxic activity of most of these compounds is essentially based on their common cationic amphiphilic properties and their capacity to perturb acidic intracellular compartments.…”
Section: Discussionmentioning
confidence: 74%
“…Epidemiological studies have repeatedly reported that individuals who are receiving long term drug treatment with antipsychotics (24,25), anti-depressant (26)(27)(28) or anti-allergic drugs (29) have a lower cancer incidence than the general population, suggesting that these medications might have a direct effect on neoplastic cells. Pre-clinical studies confirmed the direct anti-tumoral activity of these compounds in a wide range of malignancies (30)(31)(32)(33)(34). However, despite the large body of experimental evidence, the mechanisms of actions of these compounds in cancer cells remain poorly defined.…”
Section: Introductionmentioning
confidence: 99%
“…Emerging evidence has suggested that some FDA-approved antipsychotic drugs such as penfluridol, flusirilene and pimozide (typically used in the treatment of schizophrenia) may be suitable agents to repurpose in cancer treatment. These antipsychotic compounds are potent dopamine d2 and calcium channel inhibitors that are part of the diphenylbutylpiperidine class of drugs [ 108 ].…”
Section: Ion Channel Inhibitors As Therapeutic Targetsmentioning
confidence: 99%
“…Pimozide treatment of rat glioma and patient derived GBM cell lines resulted in cell cycle arrest, anti-proliferative effects and apoptosis [ 134 ]. Furthermore, pimozide may have a radio-sensitising effect, as observed in GBM mouse models, those treated with both irradiation and pimozide lived twice as long than those treated with just irradiation alone [ 108 ]. Apoptotic volume decrease is a result of fluctuations in the levels of intracellular ions, namely the loss of intracellularly K+ and is a result of decrease in ionic strength.…”
Section: Ion Channel Inhibitors As Therapeutic Targetsmentioning
confidence: 99%
“… 5 Antipsychotic drugs such as pimozide, penfluridol, fluspirilene, haloperidol, olanzapine, chlorpromazine, and reserpine have been demonstrated to exert antineoplastic effects in various cancer models. 6 , 7 , 8 , 9 , 10 , 11 In this study, we have repurposed pimavanserin tartrate (PVT) as a novel therapeutic option for pancreatic cancer. PVT was approved by the US Food and Drug Administration (FDA) in 2016 for the treatment of Parkinson disease psychosis (PDP).…”
Section: Introductionmentioning
confidence: 99%